Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
University of Nebraska
University of Nebraska
Stanford University
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)